/cloudfront-us-east-2.images.arcpublishing.com/reuters/XD6GOSUDBBKVNJVQYUEJGEVCKI.jpg?resize=400%2C240&ssl=1 "Ghana Approves Oxford Malaria Vaccine")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/XD6GOSUDBBKVNJVQYUEJGEVCKI.jpg?resize=80%2C80&ssl=1 "Ghana Approves Oxford Malaria Vaccine")
LONDON (Reuters) – A malaria vaccine under close scrutiny from the University of Oxford is now available in Ghana as the African nation ramps up its...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/UI2265OPGJMINDQILQZY7KIB2A.jpg?resize=400%2C240&ssl=1 "UK to provide COVID-19 vaccine for infants with medical conditions")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/UI2265OPGJMINDQILQZY7KIB2A.jpg?resize=80%2C80&ssl=1 "UK to provide COVID-19 vaccine for infants with medical conditions")
April 6 (Reuters) – Children aged 6 months to 4 years with underlying medical conditions will be offered a vaccination against COVID-19, Britain’s vaccine adviser said...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/CQNGOTUIPVIJDH2NOJOLFMHEUE.jpg?resize=400%2C240&ssl=1 "BioNTech Begins Clinical Trial of mRNA-Based Malaria Vaccine Candidate")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/CQNGOTUIPVIJDH2NOJOLFMHEUE.jpg?resize=80%2C80&ssl=1 "BioNTech Begins Clinical Trial of mRNA-Based Malaria Vaccine Candidate")
Berlin, December 23 (Reuters) – BioNTech (22UAy.DE) has started a first-in-human Phase 1 clinical trial of its BNT165b1 malaria vaccine candidate using mRNA technology, the German...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ECPEB5A6YRLGFOHKRDMVNPJAQE.jpg?resize=400%2C240&ssl=1 "Indonesia to produce Merck’s HPV vaccine to fight cervical cancer")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ECPEB5A6YRLGFOHKRDMVNPJAQE.jpg?resize=80%2C80&ssl=1 "Indonesia to produce Merck’s HPV vaccine to fight cervical cancer")
JAKARTA (Reuters) – Indonesia will produce a human papillomavirus (HPV) vaccine for pharmaceutical company Merck, the CEO of Indonesia’s state-owned pharmaceutical company Bio-Pharma said on Tuesday....
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ZPBS6KMKDVLWDOVDZ6BMIZ7F2E.jpg?resize=400%2C240&ssl=1 "Undetectable illness and death in African monkeypox epidemic")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ZPBS6KMKDVLWDOVDZ6BMIZ7F2E.jpg?resize=80%2C80&ssl=1 "Undetectable illness and death in African monkeypox epidemic")
Africa’s infection and death rates higher than official data Lack of Resources Hinders Containment Wealthy countries rush for available cures Africa gets left behind, repeated COVID...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/HR2P5IWZCVMNJLEFHELCBIDQNQ.jpg?resize=400%2C240&ssl=1 "India develops first cervical cancer vaccine")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/HR2P5IWZCVMNJLEFHELCBIDQNQ.jpg?resize=80%2C80&ssl=1 "India develops first cervical cancer vaccine")
Adar Poonawalla, CEO of the Serum Institute of India (SII), the world’s largest vaccine maker, speaks in an interview with Reuters at the Alpine Resort in...
Recent Comments